Renaissance Technologies
CORT icon

Renaissance Technologies’s Corcept Therapeutics CORT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$460M Buy
6,266,402
+123,371
+2% +$9.06M 0.61% 19
2025
Q1
$702M Sell
6,143,031
-55,571
-0.9% -$6.35M 1.06% 3
2024
Q4
$312M Sell
6,198,602
-310,400
-5% -$15.6M 0.46% 28
2024
Q3
$301M Sell
6,509,002
-403,569
-6% -$18.7M 0.45% 21
2024
Q2
$225M Sell
6,912,571
-205,800
-3% -$6.69M 0.38% 37
2024
Q1
$179M Buy
7,118,371
+392,500
+6% +$9.89M 0.28% 54
2023
Q4
$218M Buy
6,725,871
+111,000
+2% +$3.61M 0.34% 50
2023
Q3
$180M Sell
6,614,871
-85,100
-1% -$2.32M 0.31% 55
2023
Q2
$149M Sell
6,699,971
-88,098
-1% -$1.96M 0.21% 91
2023
Q1
$147M Sell
6,788,069
-500,802
-7% -$10.8M 0.2% 103
2022
Q4
$148M Buy
7,288,871
+91,400
+1% +$1.86M 0.2% 99
2022
Q3
$185M Sell
7,197,471
-636,400
-8% -$16.3M 0.26% 71
2022
Q2
$186M Buy
7,833,871
+63,355
+0.8% +$1.51M 0.22% 89
2022
Q1
$175M Sell
7,770,516
-253,100
-3% -$5.7M 0.21% 93
2021
Q4
$159M Sell
8,023,616
-224,225
-3% -$4.44M 0.2% 94
2021
Q3
$162M Sell
8,247,841
-274,355
-3% -$5.4M 0.21% 89
2021
Q2
$187M Sell
8,522,196
-251,600
-3% -$5.54M 0.23% 69
2021
Q1
$209M Sell
8,773,796
-567,700
-6% -$13.5M 0.26% 66
2020
Q4
$244M Sell
9,341,496
-264,500
-3% -$6.92M 0.27% 71
2020
Q3
$167M Buy
9,605,996
+686,000
+8% +$11.9M 0.17% 112
2020
Q2
$150M Buy
8,919,996
+617,155
+7% +$10.4M 0.13% 153
2020
Q1
$98.7M Buy
8,302,841
+534,627
+7% +$6.36M 0.1% 203
2019
Q4
$94M Buy
7,768,214
+1,244,005
+19% +$15.1M 0.07% 295
2019
Q3
$92.2M Buy
6,524,209
+933,700
+17% +$13.2M 0.08% 302
2019
Q2
$62.3M Buy
5,590,509
+532,700
+11% +$5.94M 0.05% 403
2019
Q1
$59.4M Buy
5,057,809
+410,600
+9% +$4.82M 0.05% 435
2018
Q4
$62.1M Buy
4,647,209
+231,609
+5% +$3.09M 0.07% 329
2018
Q3
$61.9M Buy
4,415,600
+70,200
+2% +$984K 0.06% 361
2018
Q2
$68.3M Sell
4,345,400
-453,100
-9% -$7.12M 0.07% 314
2018
Q1
$78.9M Sell
4,798,500
-156,000
-3% -$2.57M 0.09% 270
2017
Q4
$89.5M Buy
4,954,500
+1,284,745
+35% +$23.2M 0.1% 227
2017
Q3
$70.8M Buy
3,669,755
+986,355
+37% +$19M 0.08% 292
2017
Q2
$31.7M Buy
2,683,400
+824,900
+44% +$9.73M 0.04% 589
2017
Q1
$20.4M Buy
1,858,500
+351,000
+23% +$3.85M 0.03% 789
2016
Q4
$10.9M Buy
1,507,500
+947,500
+169% +$6.88M 0.02% 1165
2016
Q3
$3.64M Buy
560,000
+249,400
+80% +$1.62M 0.01% 1812
2016
Q2
$1.7M Buy
310,600
+119,200
+62% +$651K ﹤0.01% 2296
2016
Q1
$896K Sell
191,400
-269,000
-58% -$1.26M ﹤0.01% 2642
2015
Q4
$2.29M Buy
460,400
+8,200
+2% +$40.8K 0.01% 2017
2015
Q3
$1.7M Sell
452,200
-49,414
-10% -$186K ﹤0.01% 2100
2015
Q2
$3.02M Buy
501,614
+446,214
+805% +$2.68M 0.01% 1784
2015
Q1
$310K Buy
+55,400
New +$310K ﹤0.01% 2758